Mesa Laboratories (NASDAQ:MLAB) Trading 4.7% Higher

Mesa Laboratories, Inc. (NASDAQ:MLABGet Free Report) shares traded up 4.7% on Wednesday . The company traded as high as $104.91 and last traded at $104.11. 14,753 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 51,213 shares. The stock had previously closed at $99.40.

Analyst Ratings Changes

Separately, Evercore ISI upgraded Mesa Laboratories from an “in-line” rating to an “outperform” rating and increased their price target for the company from $100.00 to $125.00 in a research note on Thursday, January 4th.

Get Our Latest Analysis on Mesa Laboratories

Mesa Laboratories Stock Up 0.4 %

The company has a current ratio of 2.68, a quick ratio of 1.86 and a debt-to-equity ratio of 0.58. The stock has a market cap of $537.92 million, a P/E ratio of 615.04 and a beta of 0.83. The firm has a 50-day simple moving average of $102.22 and a two-hundred day simple moving average of $100.17.

Mesa Laboratories (NASDAQ:MLABGet Free Report) last posted its quarterly earnings data on Monday, February 5th. The medical instruments supplier reported $1.46 earnings per share for the quarter, missing the consensus estimate of $1.47 by ($0.01). The firm had revenue of $53.47 million for the quarter, compared to the consensus estimate of $54.90 million. Mesa Laboratories had a return on equity of 7.41% and a net margin of 0.45%. Equities research analysts expect that Mesa Laboratories, Inc. will post 6.15 earnings per share for the current fiscal year.

Institutional Trading of Mesa Laboratories

Several large investors have recently bought and sold shares of the business. Point72 Hong Kong Ltd acquired a new stake in shares of Mesa Laboratories during the first quarter valued at about $27,000. Quadrant Capital Group LLC boosted its stake in shares of Mesa Laboratories by 515.6% during the fourth quarter. Quadrant Capital Group LLC now owns 277 shares of the medical instruments supplier’s stock valued at $29,000 after purchasing an additional 232 shares in the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main acquired a new stake in shares of Mesa Laboratories during the second quarter valued at about $41,000. Tower Research Capital LLC TRC boosted its stake in shares of Mesa Laboratories by 235.2% during the first quarter. Tower Research Capital LLC TRC now owns 295 shares of the medical instruments supplier’s stock valued at $52,000 after purchasing an additional 207 shares in the last quarter. Finally, Amundi acquired a new stake in shares of Mesa Laboratories during the fourth quarter valued at about $102,000. 90.60% of the stock is owned by institutional investors and hedge funds.

Mesa Laboratories Company Profile

(Get Free Report)

Mesa Laboratories, Inc develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions.

Featured Articles

Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.